Spectrum Phamaceuticals Inc. (NASDAQ: SPPI) has agreed to acquire rival drug firm Allos Therapeutics Inc. (NASDAQ: ALTH) for $1.82 in cash and one Contingent Value Right (CVR), in a deal worth about $206 million, or $108 million net …
Still, the company’s stock fell today about 1.7 percent as of 11:17 a.m. to $65.00. The move is expected to cut 6 to 9 cents of revenue per share this year, and about 17 cents annually next year. So far rival pharmacy chains such as …
a stock not made from powders) can quell inflammation, speed healing, calm allergies and combat fatigue. TIME Health Newsletter Get the latest health and science news, plus: burning questions and expert tips. View Sample It can do all …
The study is comparing the drug plus the current standard of care against the current standard of care alone. Allos Therapeutics (ALTH) will be announcing results of a mid-stage study of its blood cancer drug Folotyn for the treatment …
But the cast did sneak into New York last week for stealth publicity: they rang the opening bell at the New York stock
NEW YORK, Jan 16 (Reuters) - World stock markets slipped on Tuesday, giving back early gains as Wall Street pulled back from initial highs after a decline in oil and metals dragged energy and materials stocks lower. Wall Street had …
The sellers on the marketplace have picked up almost 60% of the stock of what it had done for the Big Billion Days sale from the brands. The festive season is the biggest bet for the two ecommerce giants, both in terms of sales and …
However, public health research on gun violence is not advocacy. That last part is debatable, to say the least. In …
On Saturday, we published a new test designed to allow readers to test their “Wealth Beta.” It’s a kind of risk diagnosis for today’s wealthy and future wealthy. In my book, I describe our new age of the High-Beta Rich – i.e., millionaires and ...
In 2009, when President Barack Obama first promised that people who liked their insurance coverage would be able to keep it under the Affordable Care Act, he overlooked one critical fact: Many of the health policies that Americans like …